blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1473292

EP1473292 - Aromatic heterocyclic compounds as anti-inflammatory agents [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  07.04.2006
Database last updated on 19.10.2024
Most recent event   Tooltip07.04.2006Application deemed to be withdrawnpublished on 24.05.2006  [2006/21]
Applicant(s)For all designated states
Boehringer Ingelheim Pharmaceuticals, Inc.
900 Ridgebury Road Ridgefield
Connecticut 06877 / US
[N/P]
Former [2004/45]For all designated states
Boehringer Ingelheim Pharmaceuticals, Inc.
900 Ridgebury Road
Ridgefield Connecticut 06877 / US
Inventor(s)01 / Regan, John, R.
287 Rockingstone Avenue
Larchmont NY 10538 / US
02 / Cirillo, Pier, F.
180 Washington Road
Woodbury CT 06798 / US
03 / Hickey, Eugene, R.
5 Woodbury Drive
DanburyCT 06811 / US
04 / Moss, Neil
199 Barlow Mountain
Ridgefield CT 06877 / US
05 / Cywin, Charles, L.
37 Quaker Ridge Road
Bethel CT 06801 / US
06 / Pargellis, Christopher
18 Limekiln Road
Redding CT 06896 / US
07 / Gilmore, Thomas A.
12 Andover Street
Salem, MA 01970 / US
 [2004/45]
Representative(s)Kläs, Heinz-Gerd, et al
Boehringer Ingelheim GmbH & Co.KG
Patent Department
Binger Strasse 173
55216 Ingelheim/Rhein / DE
[N/P]
Former [2004/45]Kläs, Heinz-Gerd, et al
Boehringer Ingelheim GmbH & Co.KG, Patent Department Binger Strasse 173
55216 Ingelheim/Rhein / DE
Application number, filing date04008840.329.10.1998
[2004/45]
Priority number, dateUS19970064102P03.11.1997         Original published format: US 64102 P
[2004/45]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1473292
Date:03.11.2004
Language:EN
[2004/45]
Search report(s)(Supplementary) European search report - dispatched on:EP06.09.2004
ClassificationIPC:C07D333/36, C07D231/40, C07D235/30, A61K31/38, A61K31/415
[2004/45]
CPC:
C07D235/30 (EP); C07D231/40 (EP); C07D333/36 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2004/45]
TitleGerman:Aromatische heterocyclische Verbindungen als antiinflammatorische Mittel[2004/45]
English:Aromatic heterocyclic compounds as anti-inflammatory agents[2004/45]
French:Composes heterocycliques aromatiques convenant en tant qu'agents anti-inflammatoires[2004/45]
Examination procedure03.05.2005Examination requested  [2005/26]
13.06.2005Despatch of a communication from the examining division (Time limit: M04)
25.10.2005Application deemed to be withdrawn, date of legal effect  [2006/21]
21.12.2005Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2006/21]
Parent application(s)   TooltipEP98957405.8  / EP1028953
Fees paidRenewal fee
16.08.2004Renewal fee patent year 03
16.08.2004Renewal fee patent year 04
16.08.2004Renewal fee patent year 05
16.08.2004Renewal fee patent year 06
02.11.2004Renewal fee patent year 07
31.10.2005Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]DE2239311  (FERLUX COURNON D AUVERGNE FRAN) [X] 1-11 * Claims 1-8; Formula (I); compounds 27-362, 34, 41-43, 47-48, 52, 55, 60, 63, 76; example XIV *;
 [X]US3990879  (SOPER QUENTIN FRANCIS) [X] 1-11 * Formula of claim 1; Compounds 1-44 *;
 [X]US4171364  (PAGET CHARLES J [US], et al) [X] 1-11 * Formula of claim 1; Tables 1-8, 11-12 *;
 [X]US4265900  (RASMUSSEN C ROYCE, et al) [X] 1-11 * Claims 1-11; Table I *;
 [X]US4435567  (LUGOSI GYOERGY [HU], et al) [X] 1-11 * Claim 1; Formula (I); col. 1, l. 50-52 *;
 [X]US4576629  (MORLAND ROBERT B [US], et al) [X] 1-11 * Claims 1-18; compounds 19, 28 *;
 [X]EP0395144  (SHELL INT RESEARCH [NL]) [X] 1-11 * Claim 1; Formula (I); p. 5, l. 2-3; example 2 *;
 [X]EP0418071  (PFIZER [US]) [X] 1-11 * Claim 1; Formulae (I), (XXV) *;
 [X]US5162360  (CRESWELL MARK W [US], et al) [X] 1-11 * Claims 1-5; Formula (I); examples 1-25; schemes I-VII *;
 [X]WO9324458  (PFIZER [US], et al) [X] 1-11 * Claim 1; Formula (I) *;
 [X]WO9418170  (SMITHKLINE BEECHAM PLC [GB], et al) [X] 1-11 * Claim 1; p.2, l. 9-12 *;
 [X]WO9621654  (SMITHKLINE BEECHAM CORP [US], et al) [X] 1-11 * Claims 1-32; Forumla (I); p. 5, l. 32-p. 6, l. 15; p. 10, l.15-21; p. 11, l. 9-10; example 7; page 1 - page 5, line 25 *;
 [A]US5624931  (OKU TERUO [JP], et al) [A] 1-11 * Claim 1; Formula (I); col. 1, l. 12-29 *;
 [X]WO9716442  (MERCK & CO INC [US], et al) [X] 1-11 * Claims 1-39; Formula (I); p. 9, l. 18-p. 10, l. 17; p. 37, l. 9-p. 39, l. 5 *;
 [PX]WO9824768  (BANYU PHARMA CO LTD [JP], et al) [PX] 1-11 * Claims 1-10; Formula (I) *;
 [E]WO9932110  (BAYER AG [US]) [E] 1-11 * the whole document *;
 [E]WO9932111  (BAYER AG [US]) [E] 1-11 * the whole document *;
 [E]WO9932455  (BAYER AG [US]) [E] 1-11 * the whole document *;
 EP0955293  [ ] (BANYU PHARMA CO LTD [JP]);
 [X]  - A. MICHAELIS, "Über 5-Aminopyrazole und über Iminopyrine", JUSTUS LIEBIG ANN. CHEM., (1913), vol. 397, pages 119 - 148, XP009035295 [X] 1-11 * compounds on p. 143-144 *

DOI:   http://dx.doi.org/10.1002/jlac.19133970202
 [X]  - E. V. MEYER, "Untersuchungen aus dem organ.-chem. Laboratorium der Technischen Hochschule zu Dresden. CVI. Neue Beiträge zur Kenntnis der dimolekularen Nitrile", J. PRAKT. CHEM., (1914), vol. 90, page 1-52, XP009035294 [X] 1-11 * p. 6-7 *

DOI:   http://dx.doi.org/10.1002/prac.19140900101
 [X]  - CRANK G ET AL, "Derivatives of 2-Aminooxazoles Showing Antiinflammatory Activity", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (1971), vol. 14, no. 11, ISSN 0022-2623, pages 1075 - 1077, XP002280888 [X] 1-11 * Compounds 21-25 *

DOI:   http://dx.doi.org/10.1021/jm00293a014
 [X]  - RAM S ET AL, "SYNTHESIS OF POTENTIAL ANTIFILARIAL AGENTS. 1. 1.(5-BENZOLYLBENZIMIDAZOL-2-YL)-3-ALKYL-AND -ARYLUREAS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (1984), vol. 27, no. 7, ISSN 0022-2623, pages 914 - 917, XP002914400 [X] 1-11 * Compounds 12-20 *

DOI:   http://dx.doi.org/10.1021/jm00373a017
 [X]  - EJMOCKI Z ET AL, "SYNTHESIS OF 5-MONO-,DI-, AND TRICHLOROMETHYLSULFONYL BENZIMIDAZO- LEUREA AND BEZIMIDAZOLETHIOCARBAMAGE DERIVATIVES", POLISH JOURNAL OF CHEMISTRY, POLISH CHEMICAL SOCIETY, XX, (1985), vol. 59, pages 1279 - 1284, XP002914401 [X] 1-11 * Compounds 4-6, 8-10, 12-14 *
 [X]  - HUSSEIN A H ET AL, "synthesis of 2-[N-alkyl(aryl)carbamoylamino]-5-alkyl(alkenyl)thio-1,3 ,4-thiadiazoles", CHEMICAL ABSTRACTS + INDEXES, AMERICAN CHEMICAL SOCIETY. COLUMBUS, US, (19970421), vol. 16, no. 126, ISSN 0009-2258, XP002092279 [X] 1-11 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.